B of A Securities analyst Omar Dessouky reinstates SciPlay (NASDAQ:SCPL) with a Underperform and announces $10 price target.
Recro Pharma Q2 EPS $0.03 Beats $(0.11) Estimate, Sales $18.02M Beat $17.10M Estimate
Recro Pharma (NASDAQ:REPH) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.11) by 127.27 percent. This is a 112 percent increase over losses of $(0.25) per share from the
